{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:29:52Z","timestamp":1777836592167,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijcard.2020.08.089","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T10:59:44Z","timestamp":1598698784000},"page":"100-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies"],"prefix":"10.1016","volume":"323","author":[{"given":"J\u00fcrgen","family":"Kuschyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"M\u00fcller-Leisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"T\u00fcl\u00fcmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Fastenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Fastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Kruska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Liebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Veltmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Rudic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.08.089_bb0005","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0010","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.2013.4982","article-title":"Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention","volume":"309","author":"Peterson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2020.08.089_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.hrthm.2009.02.024","article-title":"Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure","volume":"6","author":"Hauser","year":"2009","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hrthm.2008.01.009","article-title":"Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications","volume":"5","author":"Jones","year":"2008","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0025","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.08.089_bb0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.08.089_bb0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies","volume":"3","author":"Basu-Ray","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study","volume":"10","author":"Kobe","year":"2013","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0045","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eux026","article-title":"Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement","volume":"20","author":"Mithani","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2020.08.089_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008782","article-title":"Subcutaneous implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a transatlantic experience","volume":"7","author":"Orgeron","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2019.01.041","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: results from an Italian multicenter registry","volume":"280","author":"Migliore","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0065","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0070","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0075","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0080","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.joa.2015.12.001","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"32","author":"Wilkoff","year":"2016","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0090","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006265","article-title":"Low prevalence of inappropriate shocks in patients with inherited arrhythmia syndromes with the subcutaneous implantable defibrillator single center experience and long-term follow-up","volume":"6","author":"Rudic","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.hrthm.2019.07.004","article-title":"Oversensing issues leading to device extraction: when subcutaneous implantable cardioverter-defibrillator reached a dead-end","volume":"17","author":"Noel","year":"2020","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0110","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/jce.13894","article-title":"Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique","volume":"30","author":"Migliore","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/pace.12812","article-title":"Long-term outcomes following transvenous lead extraction","volume":"39","author":"Gomes","year":"2016","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004768","article-title":"Incidence and predictors of perioperative complications with transvenous lead extractions: real-world experience with National Cardiovascular Data Registry","volume":"11","author":"Sood","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.08.089_bb0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2018.10.026","article-title":"Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: an analysis of current clinical practice and a comparison with transvenous ICD reimplantation","volume":"16","author":"Viani","year":"2019","journal-title":"Heart Rhythm."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320337165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320337165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:50:07Z","timestamp":1759092607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320337165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S0167527320337165"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.089","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}